Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2014
05/14/2014CN102058647B 一种人参次苷h提取物及制备方法 One kind eriocitrin h ginseng extract and preparation methods
05/14/2014CN101970485B 肝素结合表皮生长因子样生长因子抗原结合蛋白 Heparin-binding epidermal growth factor-like growth factor binding protein antigen
05/14/2014CN101939336B Axl抗体 Axl antibody
05/14/2014CN101801931B 作为二氢乳清酸脱氢酶抑制剂的氮杂联苯胺基苯甲酸衍生物 As a DHODH inhibitor aza biphenyl amino acid derivatives
05/14/2014CN101795714B p53的表达促进方法和该方法中使用的p53表达促进剂 p53 and p53 expression promoting method used in the method of expression promoting agent
05/14/2014CN101675054B 环杷明内酰胺类似物及其使用方法 Cyclopamine lactam analogs and methods of use
05/14/2014CN101659657B 氰基取代的喹啉衍生物及其制备方法和用途 Cyano-substituted quinoline derivatives and their preparation and use
05/14/2014CN101544678B 麦角甾-7,22-二烯-3β-醇的用途及其配方 Ergot-7,22-diene -3β- alcohol use and recipes
05/13/2014US8722859 Multivalent antibodies and uses therefor
05/13/2014US8722700 CCI-779 formulations for parenteral administration
05/13/2014US8722694 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/13/2014US8722693 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
05/13/2014US8722672 Topical pharmaceutical composition including rel-N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4′-(trifluoromethoxY)-[1,1′-biphenyl]-3-carboxamide
05/13/2014US8722664 Spontaneously dispersible N-benzoyl staurosporine compositions
05/13/2014US8722618 IL4/IL13 binding repeat proteins and uses
05/13/2014US8722366 Methods for synthesizing sugar chains using β1,3-N-acetylglucosaminyltransferase
05/13/2014US8722051 Tweak receptor
05/13/2014US8722050 Method of treating virus-induced cancer
05/13/2014US8722036 Methods for treating malignancies using coxsackieviruses
05/13/2014US8722019 P97 fragments with transfer activity
05/13/2014CA2794919A1 Formulations and methods for preventing eyebrow hair loss
05/13/2014CA2725001C Dihydroindolone derivatives
05/13/2014CA2715324C Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
05/13/2014CA2661702C Method for producing phenoxypyridine derivative
05/13/2014CA2652365C Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
05/13/2014CA2618524C Pyrazole derivatives having tyrosine kinase activity
05/13/2014CA2611712C Combretastatin analogs with tubulin binding activity
05/13/2014CA2584681C Pearmease and suicide genes for antitumoral or antiviral treatment
05/13/2014CA2559408C Carboline derivatives useful in the inhibition of angiogenesis
05/13/2014CA2514058C Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
05/13/2014CA2270345C Immunostimulatory nucleic acid molecules
05/08/2014WO2014071402A1 Xbp1, cd138, and cs1, pharmaceutical compositions that include the peptides, and methods of using such petides and compositions
05/08/2014WO2014071378A1 Substituted indol-5-ol derivatives and their therapeutical applications
05/08/2014WO2014071355A1 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
05/08/2014WO2014071316A1 In silico identification of cancer molecular signaling pathways and drug candidates
05/08/2014WO2014071231A1 Tec family kinase inhibitor adjuvant therapy
05/08/2014WO2014071219A1 Methods and products for expressing proteins in cells
05/08/2014WO2014071138A1 Disease detection and treatment through activation of compounds using external energy
05/08/2014WO2014071125A1 Combination of anti-cd20 antibody and pi3 kinase selective inhibitor
05/08/2014WO2014071109A1 Treatment of cancers using pi3 kinase isoform modulators
05/08/2014WO2014071044A1 Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
05/08/2014WO2014071029A1 Methods and assays for treatment of bladder cancer
05/08/2014WO2014070991A2 E-selectin antagonist compounds and methods of use
05/08/2014WO2014070957A1 Antibody/drug conjugates and methods of use
05/08/2014WO2014070859A1 Stat3 dimerization inhibitors
05/08/2014WO2014070771A1 Pyrimidine nucleotides and their monophosphate prodrugs for treatment of viral infections and cancer
05/08/2014WO2014070659A1 Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
05/08/2014WO2014070523A1 Trans-clomiphene for use in cancer therapy
05/08/2014WO2014070214A1 Anti-tumor agent otx-008 targets human galectin-1
05/08/2014WO2014070111A1 A novel reagent for gene-drug therapeutics
05/08/2014WO2014069834A1 Three-dimensional crystal structure of snail and importin-beta complex, and crystallization method thereof
05/08/2014WO2014069695A1 Composition for treating pancreatic cancer and functional health food containing boswellia extract
05/08/2014WO2014069694A1 Composition for treating pancreas cancer and functional health food containing hedyotis diffusa extract
05/08/2014WO2014069693A1 Composition for treating pancreatic cancer and cosmetic composition containing pharbitidis semen extract
05/08/2014WO2014069692A1 Composition for treating renal cancer and functional health food containing inula britannica var. chinensis extract
05/08/2014WO2014069691A1 Composition for treating renal cancer and functional health food containing cnidium monnieri extract
05/08/2014WO2014069690A1 Composition for treating renal cancer and functional health food containing hedyotis diffusa extract
05/08/2014WO2014069689A1 Composition for treating renal cancer and functional health food containing saussureae radix extract
05/08/2014WO2014069688A1 Composition for treating renal cancer and cosmetic composition containing perilla seed extract
05/08/2014WO2014069687A1 Composition for treating renal cancer and cosmetic composition containing pharbitidis semen extract
05/08/2014WO2014069686A1 Composition for treating renal cancer and functional health food containing trichosanthis radix extract
05/08/2014WO2014069681A1 Cancer-targeting antibody and composition for preventing or treating cancer comprising same
05/08/2014WO2014069510A1 Novel amine derivative or salt thereof
05/08/2014WO2014069401A1 Pulmonary disease-specific therapeutic agent
05/08/2014WO2014069255A1 Anticancer agent, and combination use anticancer agent
05/08/2014WO2014068972A1 Side effect reducing agent for sorafenib
05/08/2014WO2014068585A1 Novel lyophilized compositions of cyclophosphamide
05/08/2014WO2014068553A1 Aptamers, multimeric aptamers and uses thereof
05/08/2014WO2014068542A1 Novel targets in multiple myeloma and other disorders
05/08/2014WO2014068527A1 Bruton's tyrosine kinase inhibitors
05/08/2014WO2014068514A1 Cancer treatment methods
05/08/2014WO2014068397A1 Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse
05/08/2014WO2014068300A1 Anti-s100a4 antibody molecules and their uses
05/08/2014WO2014068114A1 Radiolabelled antibody and uses thereof
05/08/2014WO2014068079A1 An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
05/08/2014WO2014067960A2 Functionalized 9-bromo-camptothecin derivatives
05/08/2014WO2014067861A1 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel
05/08/2014WO2014067610A1 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)
05/08/2014WO2014067473A1 N-(5-(quinolin-6-yl)pyridin-3-yl) benzsulfamide derivatives, preparation method and therapeutic use thereof
05/08/2014WO2014067417A1 Novel quinoline compound and use thereof
05/08/2014WO2014067379A1 Deuterated dimethyl amine parthenolide, preparation method and use thereof in drug preparation
05/08/2014WO2014067336A1 Anti-tumor bivalent platinum complex and preparation method for complex and ligand of complex
05/08/2014WO2014067002A1 Synthetic lethality and the treatment of cancer
05/08/2014WO2014066967A1 Ingenol-derived compounds that can be used for treating cancer
05/08/2014WO2014042433A3 Compounds and compositions for modulating adenosine a3 receptor activity
05/08/2014WO2014038881A3 Protein kinase inhibitor comprising pyridine derivatives
05/08/2014WO2013019615A3 Switch costimulatory receptors
05/08/2014WO2012171015A3 Therapeutic combination for cancer treatment
05/08/2014WO2012166617A3 Methods, compositions, and kits for the treatment of cancer
05/08/2014US20140128580 Antibody-drug conjugates and methods
05/08/2014US20140128392 Heterocyclic compounds for the inhibition of pask
05/08/2014US20140128328 Peptide antagonists of zonulin and methods for use of the same
05/07/2014EP2727937A1 Soluble integrin 4 mutant
05/07/2014EP2727927A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
05/07/2014EP2727921A1 2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 2
05/07/2014EP2727920A1 1,5-naphthyridine derivative or salt thereof
05/07/2014EP2727918A1 Compounds and Compositions as Protein Kinase Inhibitors
05/07/2014EP2727915A1 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
05/07/2014EP2727912A1 Crystals of glycine derivative and pharmaceutical use thereof
05/07/2014EP2727909A1 Inhibitors of focal adhesion kinase
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 2211